Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
NuShares Short-Term REIT ETF (NURE) belongs to the US Real Estate segment. SRH REIT Covered Call ETF (SRHR) is part of the Options Strategies segment. Both ETFs have the same top 3 sector exposures: and Real Estate. NURE is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.75% for SRHR. NURE is up 2.55% year-to-date (YTD) with - in YTD flows. SRHR performs better with 4.74% YTD performance, and - in YTD flows. Run a side-by-side ETF comparison of NURE and SRHR below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | NURE SRHR | -2.43%-0.79% | +5.22%+4.89% | +2.55%+4.74% | -5.69%+3.70% | +12.07%n/a | +14.66%n/a |
| Flows | NURE SRHR | -- | -- | -- | -$15M-$21K | -$26M- | +$24M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | NURE SRHR | +15.98%+13.20% | +19.61%+17.06% | +18.15%n/a | +19.79%n/a |
| Max drawdown | NURE SRHR | -4.44%-4.10% | -15.06%-13.20% | -21.13%n/a | -35.93%n/a |
| Max drawdown duration | NURE SRHR | 21d21d | 365d126d | 533dn/a | 1420dn/a |
NURE | SRHR | |
Last sale 3/11/2026 at 1:30 PM | $28.49 | $54.88 |
| Previous close 03/11/2026 | $28.89 | $55.37 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
NURE | SRHR | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
NURE | SRHR | |
|---|---|---|
| Last price | $28.49 | $54.88 |
| 1D performance | -1.37% | -0.88% |
| AuM | $31.80 M | $49.38 M |
| E/R | 0.35% | 0.75% |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
